Publication | Open Access
Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial
114
Citations
18
References
2019
Year
Nivolumab demonstrated modest antitumor activity in patients with advanced ACC. The nivolumab safety profile was consistent with previous clinical experience without any unexpected AEs in this population.
| Year | Citations | |
|---|---|---|
Page 1
Page 1